1. Home
  2. MDGL vs HLI Comparison

MDGL vs HLI Comparison

Compare MDGL & HLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$588.97

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Logo Houlihan Lokey Inc.

HLI

Houlihan Lokey Inc.

HOLD

Current Price

$175.32

Market Cap

14.4B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
HLI
Founded
2011
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
14.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MDGL
HLI
Price
$588.97
$175.32
Analyst Decision
Strong Buy
Hold
Analyst Count
14
9
Target Price
$580.77
$203.63
AVG Volume (30 Days)
268.0K
404.7K
Earning Date
11-04-2025
01-27-2026
Dividend Yield
N/A
1.38%
EPS Growth
N/A
26.59
EPS
N/A
6.19
Revenue
$740,640,000.00
$2,565,361,000.00
Revenue This Year
$435.63
$15.19
Revenue Next Year
$52.56
$13.05
P/E Ratio
N/A
$28.15
Revenue Growth
864.21
21.00
52 Week Low
$265.00
$137.99
52 Week High
$615.00
$211.78

Technical Indicators

Market Signals
Indicator
MDGL
HLI
Relative Strength Index (RSI) 58.31 43.97
Support Level $578.00 $173.68
Resistance Level $615.00 $179.31
Average True Range (ATR) 17.87 2.93
MACD -1.99 0.04
Stochastic Oscillator 65.70 27.60

Price Performance

Historical Comparison
MDGL
HLI

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About HLI Houlihan Lokey Inc.

Houlihan Lokey Inc is an investment bank with expertise in mergers and acquisitions, capital markets, financial restructuring, valuation, and strategic consulting. The firm serves corporations, institutions, and governments world-wide with offices in the United States, Europe, and the Asia-Pacific region. The company operates in three segments. In the Corporate Finance business segment, it provides M&A and capital markets advisory services. Through the Financial Restructuring business segment, the company advises on some of the complex restructurings around the world. The Financial and Valuation Advisory Services business segment provides valuation and financial opinion, and financial and strategic consulting practices in the United States.

Share on Social Networks: